Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313830071> ?p ?o ?g. }
- W4313830071 abstract "Abstract Background Hepatocellular Carcinoma (HCC) is one of the major malignant tumors threatening human health. Lenvatinib resistance seriously restricts the efficacy of HCC, but the specific mechanism is not clear. Circular RNA (circRNA) plays an important role in the regulation of tumor drug resistance. Methods Key circRNA was screened by bioinformatics methods, and further identified by relevant validation experiments and HCC tissue samples. And, circRNA was evaluated as a diagnostic and prognostic marker for HCC progression at the clinical level. After then, through in vivo and in vitro experiments, the specific mechanism of the circRNA on the progression of HCC and lenvatinib resistance was explored at the molecular level. Results circRNA_0009792 (circRNA-mTOR) was highly expressed in HCC and is closely related to the prognosis of patients, which has good diagnostic value and clinical significance. In vivo and in vitro experiments showed that circRNA-mTOR could promote the progression of hepatocellular carcinoma and promote lenvatinib resistance by improving the stemness of HCC cells. Mechanismly, circRNA-mTOR could affect RNA-binding protein (PSIP1) nuclear translocation by specifically binding to it, and then which enhanced the stemness of HCC cells through PSIP1/c-Myc axis, hence promoting the progression of HCC and lenvatinib resistance. And furthermore, circRNA-mTOR at least partially induce lenvatinib resistance by increasing the expression of EGFR in HCC. Conclusions In conclusion, this study suggests that circRNA-mTOR can affect PSIP1/c-myc axis nuclear translocation, to make progress of HCC and the maintenance of steness of liver cancer cell to aggravate lenvatinib resistance, And partially increased EGFR over-expression to making chemo-resistance worse. CircRNA-mTOR has the potential to be a biomarker for the diagnosis and prognosis of HCC. This study provides a certain experimental basis for the targeted drug therapy of HCC, and puts forward new ideas, new insights and new methods in understanding the occurrence and development of HCC, and it is of great significance to seek new markers and targets for the diagnosis and treatment of HCC and reduce drug resistance." @default.
- W4313830071 created "2023-01-09" @default.
- W4313830071 creator A5003775817 @default.
- W4313830071 creator A5008812639 @default.
- W4313830071 creator A5016345843 @default.
- W4313830071 creator A5022984632 @default.
- W4313830071 creator A5033033007 @default.
- W4313830071 creator A5033435747 @default.
- W4313830071 creator A5045742566 @default.
- W4313830071 creator A5050173038 @default.
- W4313830071 creator A5067017092 @default.
- W4313830071 creator A5072070444 @default.
- W4313830071 creator A5088900142 @default.
- W4313830071 date "2023-01-09" @default.
- W4313830071 modified "2023-10-14" @default.
- W4313830071 title "CircRNA-mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance via PSIP1/c-Myc Axis Nuclear Translocation and Partially through Increasing EGFR Expression" @default.
- W4313830071 cites W1966411071 @default.
- W4313830071 cites W1998728654 @default.
- W4313830071 cites W2004878973 @default.
- W4313830071 cites W2021580214 @default.
- W4313830071 cites W2049937448 @default.
- W4313830071 cites W2054891772 @default.
- W4313830071 cites W2055493067 @default.
- W4313830071 cites W2058835062 @default.
- W4313830071 cites W2064165694 @default.
- W4313830071 cites W2114293452 @default.
- W4313830071 cites W2124006359 @default.
- W4313830071 cites W2127800890 @default.
- W4313830071 cites W2257525665 @default.
- W4313830071 cites W2292650015 @default.
- W4313830071 cites W2318224129 @default.
- W4313830071 cites W2329314689 @default.
- W4313830071 cites W2587927286 @default.
- W4313830071 cites W2598230851 @default.
- W4313830071 cites W2605526341 @default.
- W4313830071 cites W2740618823 @default.
- W4313830071 cites W2765658585 @default.
- W4313830071 cites W2784901213 @default.
- W4313830071 cites W2787358630 @default.
- W4313830071 cites W2791997421 @default.
- W4313830071 cites W2792171966 @default.
- W4313830071 cites W2795700560 @default.
- W4313830071 cites W2797653985 @default.
- W4313830071 cites W2807407703 @default.
- W4313830071 cites W2883204623 @default.
- W4313830071 cites W2886257694 @default.
- W4313830071 cites W2943966438 @default.
- W4313830071 cites W2951390905 @default.
- W4313830071 cites W2952776850 @default.
- W4313830071 cites W2962699208 @default.
- W4313830071 cites W2963653570 @default.
- W4313830071 cites W2966474615 @default.
- W4313830071 cites W2985015507 @default.
- W4313830071 cites W2999417355 @default.
- W4313830071 cites W2999417855 @default.
- W4313830071 cites W3003236397 @default.
- W4313830071 cites W3005526718 @default.
- W4313830071 cites W3008789061 @default.
- W4313830071 cites W3015424770 @default.
- W4313830071 cites W3027669624 @default.
- W4313830071 cites W3037237663 @default.
- W4313830071 cites W3048207335 @default.
- W4313830071 cites W3082759642 @default.
- W4313830071 cites W3109268452 @default.
- W4313830071 cites W3112998712 @default.
- W4313830071 cites W3117640930 @default.
- W4313830071 cites W3128646645 @default.
- W4313830071 cites W3154884425 @default.
- W4313830071 cites W3168638930 @default.
- W4313830071 cites W3170501864 @default.
- W4313830071 cites W3171159909 @default.
- W4313830071 cites W3172786496 @default.
- W4313830071 cites W3183709015 @default.
- W4313830071 cites W3196336586 @default.
- W4313830071 cites W3205213297 @default.
- W4313830071 cites W3206219396 @default.
- W4313830071 cites W3206481891 @default.
- W4313830071 cites W3207216874 @default.
- W4313830071 cites W3207337077 @default.
- W4313830071 cites W3208701685 @default.
- W4313830071 cites W3211142434 @default.
- W4313830071 cites W3212440187 @default.
- W4313830071 cites W3213325263 @default.
- W4313830071 cites W3214818744 @default.
- W4313830071 cites W3216584186 @default.
- W4313830071 cites W4200077999 @default.
- W4313830071 cites W4206568576 @default.
- W4313830071 cites W4207017806 @default.
- W4313830071 cites W4285820483 @default.
- W4313830071 doi "https://doi.org/10.21203/rs.3.rs-2437109/v1" @default.
- W4313830071 hasPublicationYear "2023" @default.
- W4313830071 type Work @default.
- W4313830071 citedByCount "0" @default.
- W4313830071 crossrefType "posted-content" @default.
- W4313830071 hasAuthorship W4313830071A5003775817 @default.
- W4313830071 hasAuthorship W4313830071A5008812639 @default.
- W4313830071 hasAuthorship W4313830071A5016345843 @default.
- W4313830071 hasAuthorship W4313830071A5022984632 @default.
- W4313830071 hasAuthorship W4313830071A5033033007 @default.
- W4313830071 hasAuthorship W4313830071A5033435747 @default.